{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T12:57:34Z","timestamp":1793451454864,"version":"4.5.0"},"reference-count":62,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["21702-5012 grant (W81XWH-14-1-0321)"],"award-info":[{"award-number":["21702-5012 grant (W81XWH-14-1-0321)"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Kasetsart University, Thailand","award":["no grant number"],"award-info":[{"award-number":["no grant number"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Veterinary Sciences"],"abstract":"<jats:p>Human Dickkopf-1 (Dkk-1) upregulates a noncanonical Wnt\/JNK pathway, resulting in osteoclast stimulation, cell proliferation, and epithelial-to-mesenchymal transition (EMT) of cancer cells. Ace-1-Dkk-1, a canine prostate cancer (PCa) cell line overexpressing Dkk-1, was used to investigate Wnt signaling pathways in PCa tumor growth. SP600125, a JNK inhibitor, was used to examine whether it would decrease tumor growth and bone tumor phenotype in canine PCa cells in vitro and in vivo. Ace-1-VectorYFP-Luc and Ace-1-Dkk-1YFP-Luc cells were transplanted subcutaneously, while Ace-1-Dkk-1YFP-Luc was transplanted intratibially into nude mice. The effects of Dkk-1 and SP600125 on cell proliferation, in vivo tumor growth, and bone tumor phenotype were investigated. The mRNA expression levels of Wnt\/JNK-related genes were measured using RT-qPCR. Dkk-1 significantly increased the mRNA expression of Wnt\/JNK-signaling-related genes. SP600125 significantly upregulated the mRNA expression of osteoblast differentiation genes and downregulated osteoclastic-bone-lysis-related genes in vitro. SP600125 significantly decreased tumor volume and induced spindle-shaped tumor cells in vivo. Mice bearing intratibial tumors had increased radiographic density of the intramedullary new bone, large foci of osteolysis, and increased cortical lysis with abundant periosteal new bone formation. Finally, SP600125 has the potential to serve as an alternative adjuvant therapy in some early-stage PCa patients, especially those with high Dkk-1 expression.<\/jats:p>","DOI":"10.3390\/vetsci8080153","type":"journal-article","created":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T21:46:44Z","timestamp":1627854404000},"page":"153","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Effect of Dickkopf-1 (Dkk-1) and SP600125, a JNK Inhibitor, on Wnt Signaling in Canine Prostate Cancer Growth and Bone Metastases"],"prefix":"10.3390","volume":"8","author":[{"given":"Wachiraphan","family":"Supsavhad","sequence":"first","affiliation":[{"name":"Department of Veterinary Biosciences, College of Veterinary Medicine, The Ohio State University, Columbus, OH 43210, USA"},{"name":"Department of Pathology, Faculty of Veterinary Medicine, Kasetsart University, Bangkok 10900, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0026-5239","authenticated-orcid":false,"given":"Bardes B.","family":"Hassan","sequence":"additional","affiliation":[{"name":"Department of Veterinary Biosciences, College of Veterinary Medicine, The Ohio State University, Columbus, OH 43210, USA"},{"name":"Department of Pathology, Faculty of Veterinary Medicine, Cairo University, Giza 12211, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica K.","family":"Simmons","sequence":"additional","affiliation":[{"name":"Department of Veterinary Biosciences, College of Veterinary Medicine, The Ohio State University, Columbus, OH 43210, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wessel P.","family":"Dirksen","sequence":"additional","affiliation":[{"name":"Department of Veterinary Biosciences, College of Veterinary Medicine, The Ohio State University, Columbus, OH 43210, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Said M.","family":"Elshafae","sequence":"additional","affiliation":[{"name":"Department of Veterinary Biosciences, College of Veterinary Medicine, The Ohio State University, Columbus, OH 43210, USA"},{"name":"Department of Neuroscience and Pharmacology, University of Iowa, Iowa, IA 52242, USA"},{"name":"Department of Pathology, Faculty of Veterinary Medicine, Benha University, Kalyubia 13736, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole A.","family":"Kohart","sequence":"additional","affiliation":[{"name":"Department of Veterinary Biosciences, College of Veterinary Medicine, The Ohio State University, Columbus, OH 43210, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aylin A.","family":"Demirer","sequence":"additional","affiliation":[{"name":"Department of Veterinary Biosciences, College of Veterinary Medicine, The Ohio State University, Columbus, OH 43210, USA"},{"name":"Pathology Department, Faculty of Veterinary Medicine, Bursa Uludag University, Bursa 16059, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Rosol","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Heritage College of Osteopathic Medicine, Ohio University, Athens, OH 45701, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,8,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21654","article-title":"Cancer Statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1002\/pros.20805","article-title":"Dickkopf-1 expression increases early in prostate cancer development and decreases during progression from primary tumor to metastasis","volume":"68","author":"Hall","year":"2008","journal-title":"Prostate"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s10555-013-9480-2","article-title":"Bone-targeting agents in prostate cancer","volume":"33","author":"Suzman","year":"2014","journal-title":"Cancer Metastasis Rev."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/pros.21277","article-title":"Dickkopf-1 (DKK-1) stimulated prostate cancer growth and metastasis and inhibited bone formation in osteoblastic bone metastases","volume":"71","author":"Thudi","year":"2011","journal-title":"Prostate"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1083\/jcb.201207142","article-title":"Canonical Wnt signaling inhibits osteoclastogenesis independent of osteoprotegerin","volume":"200","author":"Albers","year":"2013","journal-title":"J. Cell Biol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2741\/3673","article-title":"Regulatory mechanism of osteoclastogenesis by RANKL and Wnt signals","volume":"16","author":"Takahashi","year":"2011","journal-title":"Front. Biosci."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.devcel.2005.02.017","article-title":"Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation","volume":"8","author":"Glass","year":"2005","journal-title":"Dev. Cell"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1242\/jcs.02883","article-title":"Wnt signalling in osteoblasts regulates expression of the receptor activator of NFkappaB ligand and inhibits osteoclastogenesis in vitro","volume":"119","author":"Spencer","year":"2006","journal-title":"J. Cell Sci."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/nm.2653","article-title":"Wnt5a-Ror2 signaling between osteoblast-lineage cells and osteoclast precursors enhances osteoclastogenesis","volume":"18","author":"Maeda","year":"2012","journal-title":"Nat. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2014.08.005","article-title":"Targeting the Wnt pathway in human cancers: Therapeutic targeting with a focus on OMP-54F28","volume":"146","author":"Le","year":"2015","journal-title":"Pharmacol. Ther."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1124\/pr.110.002931","article-title":"International Union of Basic and Clinical Pharmacology. LXXX. The class Frizzled receptors","volume":"62","author":"Schulte","year":"2010","journal-title":"Pharmacol. Rev."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S8756-3282(03)00026-7","article-title":"Activation of the JNK\u2013AP-1 signal transduction pathway is associated with pathogenesis and progression of human osteosarcomas","volume":"32","author":"Papachristou","year":"2003","journal-title":"Bone"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"13681","DOI":"10.1073\/pnas.251194298","article-title":"SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase","volume":"98","author":"Bennett","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"17090","DOI":"10.1074\/jbc.M307629200","article-title":"JNK regulates HIPK3 expression and promotes resistance to Fas-mediated apoptosis in DU 145 prostate carcinoma cells","volume":"279","author":"Curtin","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_15","first-page":"391","article-title":"C-Jun NH(2)-terminal kinase mediates proliferation and tumor growth of human prostate carcinoma","volume":"9","author":"Yang","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/jcb.28870","article-title":"Peimine inhibits the growth and motility of prostate cancer cells and induces apoptosis by disruption of intracellular calcium homeostasis through Ca(2+) \/CaMKII\/JNK pathway","volume":"121","author":"Tan","year":"2020","journal-title":"J. Cell BioChem."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"E131","DOI":"10.1038\/ncb0502-e131","article-title":"AP-1 as a regulator of cell life and death","volume":"4","author":"Shaulian","year":"2002","journal-title":"Nat. Cell Biol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1038\/nrc1209","article-title":"AP-1: A double-edged sword in tumorigenesis","volume":"3","author":"Eferl","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1096\/fj.03-0132fje","article-title":"Synergistic cooperation between the AP-1 and LEF-1 transcription factors in activation of the matrilysin promoter by the src oncogene: Implications in cellular invasion","volume":"17","author":"Rivat","year":"2003","journal-title":"FASEB J."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1158\/0008-5472.CAN-07-6055","article-title":"Activator protein-1 transcription factors are associated with progression and recurrence of prostate cancer","volume":"68","author":"Ouyang","year":"2008","journal-title":"Cancer Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.bbrc.2004.09.001","article-title":"Dickkopf-1 antagonizes Wnt signaling independent of beta-catenin in human mesothelioma","volume":"323","author":"Lee","year":"2004","journal-title":"BioChem. Biophys. Res. Commun."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"7469","DOI":"10.1038\/sj.onc.1210054","article-title":"Function and biological roles of the Dickkopf family of Wnt modulators","volume":"25","author":"Niehrs","year":"2006","journal-title":"Oncogene"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s10555-006-9022-2","article-title":"The role of Wnts in bone metastases","volume":"25","author":"Hall","year":"2006","journal-title":"Cancer Metastasis Rev."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Rachner, T.D., Thiele, S., Gobel, A., Browne, A., Fuessel, S., Erdmann, K., Wirth, M.P., Frohner, M., Todenhofer, T., and Muders, M.H. (2014). High serum levels of Dickkopf-1 are associated with a poor prognosis in prostate cancer patients. BMC Cancer, 14.","DOI":"10.1186\/1471-2407-14-649"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"D\u2019Amelio, P., Roato, I., Oderda, M., Soria, F., Zitella, A., Ferracini, R., Mengozzi, G., Gontero, P., and Isaia, G.C. (2014). DKK-1 in prostate cancer diagnosis and follow up. BMC Clin. Pathol., 14.","DOI":"10.1186\/1472-6890-14-11"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1002\/pros.20776","article-title":"Zoledronic acid decreased osteolysis but not bone metastasis in a nude mouse model of canine prostate cancer with mixed bone lesions","volume":"68","author":"Thudi","year":"2008","journal-title":"Prostate"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/emmm.201200228","article-title":"Selective killing of p53-deficient cancer cells by SP600125","volume":"4","author":"Jemaa","year":"2012","journal-title":"EMBO Mol. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1002\/pros.23154","article-title":"Gastrin-releasing peptide receptor (GRPr) promotes EMT, growth, and invasion in canine prostate cancer","volume":"76","author":"Elshafae","year":"2016","journal-title":"Prostate"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.cell.2017.05.016","article-title":"Wnt\/beta-Catenin Signaling, Disease, and Emerging Therapeutic Modalities","volume":"169","author":"Nusse","year":"2017","journal-title":"Cell"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/nature04185","article-title":"A dual-kinase mechanism for Wnt co-receptor phosphorylation and activation","volume":"438","author":"Zeng","year":"2005","journal-title":"Nature"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/B978-0-12-386035-4.00002-1","article-title":"New insights into the mechanism of Wnt signaling pathway activation","volume":"291","author":"Kikuchi","year":"2011","journal-title":"Int. Rev. Cell Mol. Biol."},{"key":"ref_32","first-page":"16","article-title":"Review of Animal Models of Prostate Cancer Bone Metastasis","volume":"1","author":"Simmons","year":"2014","journal-title":"Vet. Sci."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Tweedle, M.F., Ding, H., Drost, W.T., Dowell, J., Spain, J., Joseph, M., Elshafae, S.M., Menendez, M.I., Gong, L., and Kothandaraman, S. (2018). Development of an orthotopic canine prostate cancer model expressing human GRPr. Prostate.","DOI":"10.1002\/pros.23686"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1182\/blood-2008-03-145169","article-title":"The role of Dickkopf-1 in bone development, homeostasis, and disease","volume":"113","author":"Pinzone","year":"2009","journal-title":"Blood"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2174\/156720205774322557","article-title":"Vital elements of the Wnt-Frizzled signaling pathway in the nervous system","volume":"2","author":"Li","year":"2005","journal-title":"Curr. Neurovasc. Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"5785","DOI":"10.1158\/0008-5472.CAN-07-6541","article-title":"Prostate cancer induces bone metastasis through Wnt-induced bone morphogenetic protein-dependent and independent mechanisms","volume":"68","author":"Dai","year":"2008","journal-title":"Cancer Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1038\/sj.bjc.6603959","article-title":"Increased Dickkopf-1 expression in breast cancer bone metastases","volume":"97","author":"Goehrig","year":"2007","journal-title":"Br. J. Cancer"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"7554","DOI":"10.1158\/0008-5472.CAN-05-1317","article-title":"Prostate cancer cells promote osteoblastic bone metastases through Wnts","volume":"65","author":"Hall","year":"2005","journal-title":"Cancer Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"5194","DOI":"10.1158\/0008-5472.CAN-10-4374","article-title":"BMP4 promotes prostate tumor growth in bone through osteogenesis","volume":"71","author":"Lee","year":"2011","journal-title":"Cancer Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/pros.10193","article-title":"Increased expression of bone morphogenetic protein-7 in bone metastatic prostate cancer","volume":"54","author":"Masuda","year":"2003","journal-title":"Prostate"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1017\/erm.2013.2","article-title":"Differentiation of mesenchymal stem cells to osteoblasts and chondrocytes: A focus on adenosine receptors","volume":"15","author":"Carroll","year":"2013","journal-title":"Expert Rev. Mol. Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1517\/14728222.2012.728207","article-title":"Targeting the ATF4 pathway in cancer therapy","volume":"16","author":"Singleton","year":"2012","journal-title":"Expert Opin. Ther. Targets"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s13277-013-1064-9","article-title":"TR1 promotes cell proliferation and inhibits apoptosis through cyclin A and CTGF regulation in non-small cell lung cancer","volume":"35","author":"Wang","year":"2014","journal-title":"Tumour Biol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"7462","DOI":"10.1038\/sj.onc.1203151","article-title":"PTEN tumour suppressor is linked to the cell cycle control through the retinoblastoma protein","volume":"18","author":"Paramio","year":"1999","journal-title":"Oncogene"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1073\/pnas.0308217100","article-title":"Early onset of neoplasia in the prostate and skin of mice with tissue-specific deletion of Pten","volume":"101","author":"Backman","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1148\/rg.2018170108","article-title":"Prostate-specific Membrane Antigen PET: Clinical Utility in Prostate Cancer, Normal Patterns, Pearls, and Pitfalls","volume":"38","author":"Hofman","year":"2018","journal-title":"Radiographics"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"66","DOI":"10.5603\/FHC.2013.0010","article-title":"Differences in the expression of telomerase and prostate-specific membrane antigen in non-advanced prostatic cancer","volume":"51","author":"Gasinska","year":"2013","journal-title":"Folia Histochem. Cytobiol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1158\/1055-9965.EPI-13-0668","article-title":"Prostate-specific membrane antigen protein expression in tumor tissue and risk of lethal prostate cancer","volume":"22","author":"Kasperzyk","year":"2013","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1939-1676.1987.tb02013.x","article-title":"The Influence of Castration on the Development of Prostatic Carcinoma in the Dog 43 Cases (1978\u20131985)","volume":"1","author":"Obradovich","year":"1987","journal-title":"J. Vet. Intern. Med."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1046\/j.1476-5829.2003.00007.x","article-title":"Immunohistochemical characterization of canine prostatic carcinoma and correlation with castration status and castration time","volume":"1","author":"Sorenmo","year":"2003","journal-title":"Vet. Comp. Oncol."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Shorning, B.Y., Dass, M.S., Smalley, M.J., and Pearson, H.B. (2020). The PI3K-AKT-mTOR Pathway and Prostate Cancer: At the Crossroads of AR, MAPK, and WNT Signaling. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21124507"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ccr.2010.05.026","article-title":"Integrative genomic profiling of human prostate cancer","volume":"18","author":"Taylor","year":"2010","journal-title":"Cancer Cell"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"4637","DOI":"10.1111\/bph.13894","article-title":"Rationale for targeting the Wnt signalling modulator Dickkopf-1 for oncology","volume":"174","author":"Kagey","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/1097-0215(20001015)88:2<180::AID-IJC6>3.0.CO;2-H","article-title":"Alterations in the gene expression profile of MCF-7 breast tumor cells in response to c-Jun","volume":"88","author":"Johnston","year":"2000","journal-title":"Int. J. Cancer"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"6063","DOI":"10.1038\/sj.onc.1202989","article-title":"cJun overexpression in MCF-7 breast cancer cells produces a tumorigenic, invasive and hormone resistant phenotype","volume":"18","author":"Smith","year":"1999","journal-title":"Oncogene"},{"key":"ref_56","first-page":"4143","article-title":"TP53 mutation in prostate needle biopsies--comparison with patients follow-up","volume":"27","author":"Ecke","year":"2007","journal-title":"Anticancer Res."},{"key":"ref_57","first-page":"1579","article-title":"TP53 gene mutations in prostate cancer progression","volume":"30","author":"Ecke","year":"2010","journal-title":"Anticancer Res."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Sirohi, D., Devine, P., Grenert, J.P., van Ziffle, J., Simko, J.P., and Stohr, B.A. (2019). TP53 structural variants in metastatic prostatic carcinoma. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0218618"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.4143\/crt.2015.430","article-title":"Association between Mutation and Expression of TP53 as a Potential Prognostic Marker of Triple-Negative Breast Cancer","volume":"48","author":"Kim","year":"2016","journal-title":"Cancer Res. Treat."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1007\/s13277-013-1002-x","article-title":"Twist: A molecular target in cancer therapeutics","volume":"34","author":"Khan","year":"2013","journal-title":"Tumour Biol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"10801","DOI":"10.1158\/0008-5472.CAN-05-0712","article-title":"Twist overexpression induces in vivo angiogenesis and correlates with chromosomal instability in breast cancer","volume":"65","author":"Mironchik","year":"2005","journal-title":"Cancer Res."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.cell.2004.06.006","article-title":"Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis","volume":"117","author":"Yang","year":"2004","journal-title":"Cell"}],"container-title":["Veterinary Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2306-7381\/8\/8\/153\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:38:42Z","timestamp":1760164722000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2306-7381\/8\/8\/153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,1]]},"references-count":62,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2021,8]]}},"alternative-id":["vetsci8080153"],"URL":"https:\/\/doi.org\/10.3390\/vetsci8080153","relation":{},"ISSN":["2306-7381"],"issn-type":[{"value":"2306-7381","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,1]]}}}